Overview
Rui Bergantim practices practicing medicine in Porto, Portugal.
Mr. Bergantim is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Secondary Immunodeficiency (SID), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 49 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rui Bergantim
Is Rui Bergantim a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Rui Bergantim is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rui Bergantim participate in research or clinical trials?
Yes. Rui Bergantim has published 49 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Rui Bergantim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaMr. Bergantim isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Bone Marrow TransplantMr. Bergantim isAdvanced. Learn about Bone Marrow Transplant.
- Primary AmyloidosisMr. Bergantim isAdvanced. Learn about Primary Amyloidosis.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Bergantim isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Bergantim isExperienced. Learn about Agranulocytosis.
- Cardiac AmyloidosisMr. Bergantim isExperienced. Learn about Cardiac Amyloidosis.
- Chronic Inflammatory Demyelinating Polyneuropathy
- Congenital Fiber-Type DisproportionMr. Bergantim isExperienced. Learn about Congenital Fiber-Type Disproportion.
- COVID-19Mr. Bergantim isExperienced. Learn about COVID-19.
- Febrile NeutropeniaMr. Bergantim isExperienced. Learn about Febrile Neutropenia.
- Hairy Cell Leukemia (HCL)Mr. Bergantim isExperienced. Learn about Hairy Cell Leukemia (HCL).
- HypercalcemiaMr. Bergantim isExperienced. Learn about Hypercalcemia.
- LeukemiaMr. Bergantim isExperienced. Learn about Leukemia.
- Milk-Alkali SyndromeMr. Bergantim isExperienced. Learn about Milk-Alkali Syndrome.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Nemaline MyopathyMr. Bergantim isExperienced. Learn about Nemaline Myopathy.
- Secondary Immunodeficiency (SID)Mr. Bergantim isExperienced. Learn about Secondary Immunodeficiency (SID).
- Severe Acute Respiratory Syndrome (SARS)Mr. Bergantim isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Tubular Aggregate MyopathyMr. Bergantim isExperienced. Learn about Tubular Aggregate Myopathy.
- X-Linked Myotubular MyopathyMr. Bergantim isExperienced. Learn about X-Linked Myotubular Myopathy.